Income up at Bank of the Sierra

Sierra Bancorp, the parent company of Bank of the Sierra, announced a record quarter as net income grew by 16 percent from a year earlier. Bank of the Sierra is based in Porterville, in the San Joaquin Valley, and has 12 branches in the tri-county region, the result of a series of acquisitions of Central Read More →
Read More →Resonant reports earnings bump

Resonant, the Goleta-based maker of components for wireless devices, reported a sharp increase in sales and a reduced cash burn for its third quarter ended Sept. 30. The company said revenue jumped to $1.4 million, compared to $79,000 in the same quarter a year ago and $600,000 in the second quarter, as it received a Read More →
Read More →Dubroff: Mission Produce IPO holds lessons for industry, region

UPDATE: Mission Produce began trading on the Nasdaq at 12:16 p.m. on Oct. 1. Follow the stock here. The window for initial public stock offerings rarely opens as wide as it has in the fall of 2020. That’s remarkable given the COVID-19 pandemic, the election campaign and governments racking up debt like crazy. But after Read More →
Read More →Arcutis shares up on news of public, private offerings

Arcutis Biotherapeutics saw a 15 percent rise in its share price after it said Sept. 29 that it will offer 4 million shares to the public and sell another $35 million in stock to an affiliate of one of its directors. Arcutis closed at $31.04, a gain of $4.28 after it announced the dual track Read More →
Read More →Cure closes $20M CBD acquisition

Cure Pharmaceutical, an Oxnard cannabis products manufacturer, has completed its $20 million cash-and-stock buyout of the CBD company Sera Labs, a deal Cure says will help it reach positive cash flow in around 18 months. Cure’s stock, which is traded on the over-the-counter markets, fell 3 percent following the announcement, closing at $1.29 per share Read More →
Read More →Mission Produce could join three-comma club with $1B-plus IPO

Mission Produce put a $1.18 billion price tag on its avocado operation, announcing in a Sept. 23 Securities and Exchange Commission filing that it plans to raise around $106 million in its initial public offering. The Oxnard-based avocado distributor said it plans to offer some 6.25 million shares of common stock for $15-$17 per share. Read More →
Read More →